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Abstract
Umbilical cord (UC) is an important source of multipotential mesenchymal stem cells (MSCs). 
It has observed that bee venom (BV) is effective in survival and differentiation of the cells. We 
hypotheses that BV can cause differentiation of MSCs to osteocytes. The cells obtained from 
mouse UC tissues were digested and suspended in DMEM medium. After 24 hours, to induce 
osteogenic differentiation, cells were cultured for 14 and 21days respectively in DMEM medium 
contain different concentrations of BV (1,2,3,4,5,6 µgr/ml). Following the treatment, calcium’s 
level in the cells was determined by Alizarin red staining. Cytotoxic effects of BV on MSCs were 
tested by MTT assay which are shown that BV inhibits MSCs growth. Furthermore, by Alizarin 
red test, we found that BV increases calcium level in MSCs on dose and time dependent man-
ner. In conclusion we suggest that the MSCs from UC have differentiation potential to osteocyte 
under BV treatment and it may be useful in cell therapy.
Keywords: mesenchymal stem cells, Bee venom, osteogenic differentiation.
1. Introduction 
Umbilical Cord (UC) is a rich source of multipotential mesenchymal stem cells (MSCs). MSC’s 
are a type of multipotent adult stem cell that was originally described as early as the 1960’s in ani-
mal experiments [1]. Many studies have demonstrated that MSCs have an enormous therapeutic 
potential for cell therapy [2].  These cells are also considered to have regenerating potential for 
certain degenerative conditions. MSCs can be differentiate into bone, adipose, cartilage, muscle, 
and endothelium if these cells are cultured under specific conditions MSC’s is obtainable from 
placental blood, bone marrow, fatty tissue and amniotic fluid. It is also easily obtainable from 
the tissue of the cord itself [3,4]. In this study MSC’s present in the UC were selected. UC is a 
low cost source of MSCs with multiple differentiation capacities and so it is a much better source 
than other sources, such as bone marrow or fatty tissue [5,6]. Bee venom (BV) has been used for 
the treatment of chronic inflammatory diseases such as rheumatoid arthritis and relief of pain 
in oriental medicine. More recently, studies indicate that BV has potential role in cancer therapy 
[7,8]. BV contains a variety of biologically active components like melittin and phospholipase A2 
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(PLA2) [9]. Previous observations have shown that bee venom or its components are effective in 
proliferation, survival and differentiation of the cells [10]. In this view the aim of this study was 
the examination of differentiating potential of BV on MSCs. Our hypothesis is that BV could cause 
differentiation of MSCs to osteocytes.
2. Materials and methods
UC from 1-2 pregnant mice were obtained from animal lab unit in Kharazmi university which 
were killed by ether and the harvested pieces of tissue were washed several times in sterile 
phosphate-buffered saline (PBS) and then mechanically minced and enzymatically digested with 
0.25% trypsin-EDTA (Gibco-Invitrogen) for approximately 10 min at 37 ˚C. After centrifugation 
(1500rpm for 10 min), cells were collected and cultured in Dulbecco’s modified Eagle’s medium 
(Gibco-Invitrogen) supplemented by 10% fetal bovine serum (FBS), 100 U/ml penicillin-strepto-
mycin (Gibco-Invitrogen). Cell cultures were maintained at 37 ˚C with a water-saturated atmo-
sphere and 5% CO2. Medium was replaced one to two times every week. Three to 5 days after initiating incubation, to calculate the proper doses of BV that cause differentiation of MSCs and 
also have low cytotoxicity, the cells were cultured with different concentrations of BV (1–12 µgr/
ml) for 24h. Cell viability then measured by MTT assay. In continue, to induce osteogenic differ-
entiation, the cells were treated by different concentration of BV (4,5,6 µgr/ml) respectively for 14 
and 21 days.  After these times, osteogenic differentiation was analyzed by alizarin red staining.  
3. Results
Based on MTT assay, results the IC50 values of BV for MSCs were 7.5µgr/ml after 24h (fig.1). Also the results showed that BV induces cell death in MSCs in high doses while, at low doses it could 
inhibit cell growth and induce differentiation. Maximum BV-induced cytotoxicity was evident 
after 24 h exposure to 15µgr/ml concentration. Our results from alizarin red staining illustrated 
that undifferentiated MSCs (control group) showed almost no specific staining. Osteocyte-like 
cells could be seen after 14 days of osteogenic induction (Fig.2). But after 21 days of cultivation the 
overall color intensity of the differentiated MSCs was markedly enhanced (Fig.3). 
Figure 1. Effect of BV on cell viability. MSCs were treated with different concentration of BV for 24h.The cell 
viability was then determined by MTT assay, as described under Section 2. Data shown are the mean of three 
independent experiments ± SEM and are statistically significant in comparison to the control by one-way 
ANOVA.
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Figure 2. Light microscope micrograph of the alizarin red staining of MSCs following exposure to different 
concentrations of BV for 14 days. A: control group, B: 4µgr/ml BV treated cells, C: 5µgr/ml BV treated cells. D: 
6µgr/ml BV treated cells (200x magnification)
Figure 3. Light microscope micrograph of the alizarin red staining of MSCs following exposure to different 
concentrations of BV for 21 days. A: control group, B: 4µgr/ml BV treated cells, C: 5µgr/ml BV treated cells. D: 
6µgr/ml BV treated cells (200x magnification)
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4. Summary and conclusion
UC cells have many advantages because of the immaturity of newborn cells compared with 
other sources of stem cells. The UC appeared to be a source of fetal cells that could be easily used 
as multipotent stem cells [3]. Umblical cord derived mesenchymal stem cells can replicate stably 
in culture, possess the  capability to differentiate into a wide variety of tissues after culture [5]. 
In this study we reported the osteogenic differentiation of MSCs, as characterised by alizarin red 
staining. By use of key markers of osteogenic differentiation (calcium deposition), we demon-
strated that presence of BV can differentiate to osteocyte cells in the absence of osteogenic media. 
Osteogenic differentiation was greater when cultured-MSCs were treated with BV for 21 days 
rather than 14 days treatment. In conclusion, we suggest that BV can cause differentiation in the 
MSCs from UC and it may be useful in cell therapy.
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